Latest Biotech News

Pfizer has agreed to a most-favored nation drug pricing deal aimed at aligning U.S. drug prices with those in other developed nations. Under this plan, newly launched Pfizer drugs will be priced...

Genmab has agreed to acquire Dutch biotech Merus for approximately $8 billion in cash, aiming to bolster its late-stage oncology pipeline with Merus’ bispecific antibody, petosemtamab. The drug...

Innovations in artificial intelligence and machine learning are accelerating biomedical research by improving data analysis capabilities. Tools such as ROCS X by Cadence Molecular Sciences enable...

Recent studies have highlighted notable progress in cancer treatment approaches. Novel immunotherapy scaffolds and bispecific antibodies show potential for difficult cancers such as glioblastoma...

Breakthrough diagnostic imaging and biomarker technologies are improving clinical management of complex diseases. The TriVerity biomarker test outperforms established infection markers for sepsis...

Groundbreaking research continues to elucidate the role of microbiota and pathogens in health and disease. The gut microbiome shows lasting alterations in response to past medication usage,...

Innovative studies have uncovered critical molecular and cellular mechanisms across various diseases. Senescent cells are characterized as metabolically active yet dysfunctional contributors to...

New research highlights promising therapeutic interventions in respiratory and cardiovascular conditions. Biologic therapies reduce symptoms and hospitalizations in pulmonary arterial...

Recent advances are pushing the boundaries of cell and gene therapy development and manufacturing. Efficient nucleic acid quantitation technologies like Countable PCR improve accuracy for gene...

Danish biopharmaceutical company Genmab has finalized the $8 billion acquisition of Netherlands-based Merus NV, strategically expanding its cancer treatment portfolio with Merus’ late-stage...

Pfizer and the White House announced a drug pricing agreement featuring a direct-to-consumer platform named TrumpRX, aimed at lowering U.S. drug costs by offering medications at average discounts...

Pivotal clinical trials and studies have highlighted advances in radiation therapy across multiple indications. Key findings show that pulsed low-dose-rate chemoradiation effectively reduces side...

Artificial intelligence is playing an increasing role in biotechnology, enhancing drug discovery and clinical diagnostics. Cadence launched ROCS X, an AI-powered virtual screening platform...

Recent studies have decoded the evolutionary origins and expanding capabilities of CRISPR systems, underpinning revolutionary gene editing applications. Research tracing Type V CRISPR-Cas systems...

Key regulatory approvals and clinical successes are shaping the biotech landscape. The FDA approved Novartis’ BTK inhibitor remibrutinib for chronic spontaneous urticaria, expanding therapeutic...

Groundbreaking research is expanding the frontiers of immunotherapy and molecular oncology. Novel bispecific antibodies targeting tumor-specific antigens, such as EGFRxLGR5, show therapeutic...

Significant progress has been made in genomic diagnostics and biomarker identification to support personalized medicine. SumHealth partnered with Nucleus Genomics to broaden access to whole-genome...

The potential shutdown of the U.S. federal government threatens to furlough or terminate approximately 41% of the Department of Health and Human Services staff, compounding the impact of prior...

Healthcare leaders underscore the critical role of robust metrics in designing and evaluating patient engagement programs, aiming to improve therapy adherence and outcomes. Executives from Acadia...

Metsera announced interim Phase 2 results for its obesity drug MET-097i demonstrating an average placebo-adjusted body weight reduction of approximately 14% at 28 weeks, paralleling Lilly’s...